Dyne Therapeutics Inc (DYN)
Dyne Therapeutics stock today
Dyne Therapeutics closed at $16.69 on October 30, 2026, down 2.05% on the day. Over the past year it returned -29.1% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.76 billion.
| Period | DYN | S&P 500 (SPY) |
|---|---|---|
| 1 month | +3.6% | -0.9% |
| 3 months | -35.1% | +2.1% |
| Year to date | -14.7% | +11.7% |
| 1 year | -29.1% | +12.4% |
| 3 years | +128.0% | +88.5% |
| 5 years | +15.0% | +76.0% |
Key statistics
- Market value
- $2.76B
- 52-week range
- $14.25 to $26.78
- Next report
- Nov 5, 2026 (estimated)
About Dyne Therapeutics
Develops therapies for muscle disorders and neurological conditions.
Sector: Health Care
More on Dyne Therapeutics
- Returns: what $1,000 became$1,000 five years ago is $1,150 today
No forecast, no recommendation. This page describes Dyne Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.